Chlorothiazide Production Cost Reports

The report provides detailed analysis essential for establishing a chlorothiazide production plant. It encompasses all critical aspects necessary for chlorothiazide production, including the cost of chlorothiazide production, chlorothiazide plant cost, chlorothiazide production costs, and the overall chlorothiazide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a chlorothiazide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Chlorothiazide Market Analysis: Demand and Supply Analysis, and Sourcing

Chlorothiazide is a thiazide diuretic used to treat high blood pressure and fluid retention. Chemically it is a benzothiadiazine sulfonamide, the first drug of the thiazide class. It works on the kidney to increase the loss of sodium and water, which lowers blood pressure and clears fluid. The drug treats hypertension and edema from heart, liver, and other conditions. Being an old, off-patent generic, it holds a steady, niche, and specialty demand. It was the first thiazide diuretic, and newer thiazides such as hydrochlorothiazide have taken most of the volume. Today the molecule is mature, low in volume, and made by a few makers.

Buyers are a small group of pharmaceutical and generic drug makers, along with API traders. Demand runs through oral suspensions, tablets, and injectable products based on the sodium salt. Supply is concentrated in India, with some capacity in China, where diuretic makers cover the API. A chlorothiazide demand and supply analysis has to weigh the chloroaniline intermediate cost, the sulfonation and cyclization steps, a narrow diuretic base, and steady demand for specific uses. On receipt, buyers check assay by HPLC, related substances, residual solvents, heavy metals, and water content.

Summary of the Product, Grades, and Uses

Chlorothiazide carries the molecular formula C7H6ClN3O4S2 and a molar mass of 295.71 g/mol under CAS 58-94-6. It is a white to off-white crystalline powder that is practically insoluble in water and soluble in dilute alkali. The melting point runs high, around 342 to 343 °C, since the molecule is thermally stable. Being a weak acid, it forms a soluble sodium salt used in injectable products. The oral forms use the free acid, while the injection uses the sodium salt. In storage, it holds up well when kept cool, dry, sealed, and away from light.

Chlorothiazide reaches the market as the free acid and as the sodium salt at pharmaceutical grade. Pharmaceutical grade meets USP, European Pharmacopoeia, and other monographs for suspensions, tablets, and injections. Indian Pharmacopoeia grade serves the home market under the same tight limits. It ships as a fine crystalline powder to suit suspension, tablet, and injection blending. Buyers check assay by HPLC, related substances, individual impurities, residual solvents, heavy metals, and microbial limits against the specification.

Across the label, the roles center on blood pressure and fluid retention. In hypertension, it lowers blood pressure alone or with other drugs. In edema, it clears fluid from heart failure, liver disease, and other conditions. The oral suspension and the injectable form keep it useful where a tablet does not fit, including some pediatric use. Across these uses, the value comes from proven diuresis, oral and injectable forms, low cost, and a long record. Diuretic demand is steady but narrow for this older drug. Specific forms drive its use. Such lab work covers diuretic assays, method development, calibration, and analytical checks. Reference and research use is small, mostly analytical and pharmacology work in labs.

Main End-Uses of Chlorothiazide

The main use of chlorothiazide is as a diuretic and antihypertensive, and this covers most of the small demand. It goes into oral suspensions, tablets, and injectable products for blood pressure and fluid control. Buyers are pharmaceutical and generic formulators who run cardiovascular and diuretic lines. Used as a bulk active, one batch serves a large number of finished doses. On the buyer side, checks cover assay, related substances, individual impurities, and dissolution. For a diuretic API, the sensitive attributes are related substances, individual impurities, assay, and color.

Hypertension and edema treatment is the largest setting. Suspensions, tablets, and injections lower blood pressure and clear fluid, where the drug still has a role. Newer thiazides take most of the tablet volume, but chlorothiazide holds specific uses. Here the value comes from proven diuresis, the oral and injectable forms, low cost, and compendial quality. Diuretics are a mature field. Newer drugs took the volume. On uptake, the drivers are cost, dosing form, prescriber habit, and specific need. Formulators value a clean impurity profile here, since the product goes into people.

Specialty and injectable use is the second setting. In hospitals, the injectable sodium salt serves acute use where oral dosing does not fit, and the suspension suits pediatric and difficult-to-dose patients who cannot swallow tablets. Some markets keep it for these specific needs. On this outlet, buyers weigh assay, related substances, color, and reliable supply. On the specification side, the key attributes are related substances, individual impurities, assay, and color. Buyers here weigh assay, related substances, color, and price against the grade they need. Reference and comparator use accounts for the small remainder of demand, covering diuretic assays, method development, and analytical work in labs.

Chlorothiazide Market Risks

Chlorothiazide sits in the older, niche diuretic market, so its main risks are its narrow use and thin supply rather than strong demand. Demand is small and specific, since newer thiazides have taken most of the diuretic volume. The narrow, low-volume market limits how many makers stay in the product. Supply is thin, so any maker stepping back or a quality problem moves the small market. Competition from newer diuretics and combinations caps the use that remains. On balance, the main pressures are a narrow use, thin supply, competition from newer drugs, and low volume. The remaining demand is steady. Volume stays small here. Supply stays thin. Most risk sits on volume and supply.

Chlorothiazide manufacturing carries its own risks because the sulfonation and cyclization both demand tight control. The chlorosulfonation step is harsh and corrosive, so it needs careful control and materials. The cyclization to the benzothiadiazine ring has to run clean, or related substances build up. Related substances and individual impurities are tightly specified, so purification has to be thorough. The salt formation for the injectable grade has to give a consistent, stable product. Most rejected batches trace back to related substances, assay, and residual-solvent failures.

Chlorothiazide Production Process and Main Cost Drivers

The chlorothiazide production process runs the full value chain, from chloroaniline receipt through chlorosulfonation, amidation, cyclization, purification, salt formation, and drying.

1. By Chlorosulfonation of Chloroaniline and Cyclization to the Benzothiadiazine Ring: The main inputs are meta-chloroaniline, chlorosulfonic acid, ammonia, formamide or a formylating agent, sodium hydroxide for the salt, organic solvents & purified water.

Chlorothiazide production opens with receipt and QC of the meta-chloroaniline and the reagents. The chloroaniline is treated with chlorosulfonic acid, which puts sulfonyl chloride groups on the ring. This builds the disulfonyl chloride intermediate, then reaction with ammonia gives the disulfonamide. The intermediate is purified before the next step, since impurities carry forward otherwise.

Next, the disulfonamide is cyclized with formamide or a formylating agent, which closes the benzothiadiazine ring and builds chlorothiazide. The crude is worked up, then purified and either dried as the free acid or converted to the sodium salt with sodium hydroxide. Once purified, the product is crystallized, filtered, dried & milled to specification. Across the process, the critical controls are chlorosulfonation, cyclization completeness, related substances, and color. Corrosion-resistant handling runs through the sulfonation step, since chlorosulfonic acid is aggressive. QC covers assay, related substances, individual impurities, residual solvents & water content. The main levers on cost are the chloroaniline price, chlorosulfonation control, cyclization yield & purification recovery.

Main Factors Affecting Chlorothiazide Production Cost

Chlorothiazide production cost is shaped mainly by the chloroaniline and the yield of the multi-step synthesis. Meta-chloroaniline and chlorosulfonic acid are the main raw materials, and their prices drive much of the total. Because the route runs several chemical steps, yield losses compound and shape the cost per kilogram. Ammonia, formamide, sodium hydroxide & solvents are steady process costs. Energy for the reactions, purification & drying is a real utility item. On the testing side, HPLC for related substances, residual-solvent & water tests make up most of the QC spend. On the running side, the biggest cost lines are the intermediates, energy, purification, and low-volume overhead. Feedstock is the main driver. Yield losses come next.

Unit cost also moves with cyclization yield and batch size. A batch with heavy related substances or poor cyclization takes extra purification and loses yield. Because the market is small, fixed costs spread over few kilograms and lift the unit cost. Corrosive chlorosulfonation raises equipment and safety costs that have to be managed. GMP documentation, pharmacopoeia compliance & regulatory upkeep are carried as fixed overhead. The synthesis train, purification & analytical burden all carry heavy fixed overhead, so a plant running at low volume spreads that overhead over fewer kilograms and lands at a higher unit cost.

Raw Materials for Chlorothiazide Production Plant and its Procurement

Raw material sourcing for chlorothiazide centers on meta-chloroaniline and chlorosulfonic acid. Meta-chloroaniline is the primary specialty feedstock, made from chloronitrobenzene and reduction at fine-chemical plants. It ships from a limited set of makers, since it is a specialty aromatic amine. Chlorosulfonic acid, ammonia, formamide, sodium hydroxide, organic solvents & purified water complete the input streams.

Cheaper chloroaniline is not always the cheapest route to finished chlorothiazide. A feed with related impurities carries side products through the synthesis. Feedstock quality also shapes the related-substance profile, which is critical for a pharmaceutical grade. Taken together, chloroaniline purity, chlorosulfonation control, cyclization yield, solvent recovery & purification recovery drive most of the variable cost per kilogram.

Such sensitivities shape how a chlorothiazide plant buys and qualifies its inputs. Contracts specify intermediate purity, related impurities, color & moisture, and every incoming lot is quarantined until QC release. Vendor qualification runs through supplier audits, review of the synthesis chain & lot-to-lot monitoring. On the incoming side, checks cover assay, related impurities, color, and moisture. Long-term agreements with two intermediate suppliers help steady cost, timing, quality, and supply. Because chlorosulfonic acid is hazardous, careful sourcing and handling matter more than a low price alone, since safety shapes the operation.

Sustainability and Regulatory Requirements

Chlorothiazide manufacture raises environmental concerns that center on acid effluent, corrosive chemistry & salt waste. Standard controls rely on acid neutralization, chemical effluent treatment, salt and chloride control & control of organic waste before discharge. The chlorosulfonation step produces acidic and corrosive streams, so neutralization and treatment matter. Solvent recovery and energy integration cut both cost and footprint. On the sustainability side, the themes are acid neutralization, effluent treatment, solvent recovery, and energy use. Tighter environmental rules in China have already closed weaker plants and lifted compliance spending across the industry. Acid and effluent control is the sharpest issue. Full documentation is expected.

Regulatory obligations for chlorothiazide follow from its use as a prescribed diuretic. In the US, the API sits under FDA cGMP per 21 CFR 210/211 and the USP monograph. In Europe, an EU GMP site with a Certificate of Suitability to the European Pharmacopoeia is needed for regulated supply. ICH Q7 for active ingredients applies, along with BP, EP & USP limits on related substances. Indian grades follow their own pharmacopoeia limits. On the compliance side, the duties span cGMP, the compendial monograph, impurity limits, and effluent standards. Sites usually carry ISO 14001 and ISO 45001 certification, and batch release rests on assay, related substances, individual impurities & microbial limits.

CAPEX and OPEX for a Chlorothiazide Production Plant

A chlorothiazide plant is a multi-step synthesis and purification facility built around corrosive chemistry. Plant investment starts with chloroaniline and reagent storage, a chlorosulfonation reactor in corrosion-resistant materials, and an amidation section. From there come a cyclization reactor, a purification and salt-forming step, and a crystallization, drying & milling suite. Utilities cover chilled brine, steam, purified water, solvent recovery, acid handling & an effluent treatment plant. On the QC side, a laboratory block houses HPLC, related-substance testing, residual-solvent & water analysis. Civil works provide contained reactor bays, an acid and solvent store, a drying and packing area & a controlled-access warehouse. On the capital side, the big blocks are the chlorosulfonation reactor, the purification train, the effluent plant, and the drying suite. Corrosion-resistant handling runs through the sulfonation step, since chlorosulfonic acid is aggressive.

Chlorothiazide operating cost comes from the same inputs and control points that shape the process. The variable side is led by meta-chloroaniline, chlorosulfonic acid, ammonia, formamide & solvents, alongside energy, labor, testing, effluent treatment, packaging & freight. Cost per kilogram then comes down to chlorosulfonation control, cyclization yield & purification recovery. The chlorothiazide plant setup cost depends on capacity, synthesis and purification scale, corrosion and safety scope & grade range. Taken together, chloroaniline price, chlorosulfonation control, cyclization yield, energy use & compliance determine the running cost.

Plant Location and Investment Factors

A workable chlorothiazide site sits inside a fine-chemical cluster with chloroaniline supply and strong effluent infrastructure. Access to trained synthesis and QC staff is essential. India's fine-chemical hubs pair chloroaniline supply with diuretic chemistry and formulation capacity. China adds intermediate and API capacity with a low cost base and large chemical infrastructure. Both regions offer supplier networks, safe-handling capability & established supply chains. The site also needs acid handling, solvent recovery & a full effluent treatment plant for chemical waste.

For a chlorothiazide plant, the main investment decision is whether the small, niche market justifies dedicated capacity or fits inside a multipurpose plant. A multipurpose facility spreads the low-volume cost across several products, which suits small chlorothiazide volumes. Whether to make the free acid, the sodium salt, or both is the other decision, since the injectable salt needs an extra step and tighter control. Plant scale has to match a small, steady, and price-sensitive market, so the project rests on flexibility and reliable quality. For a maker targeting regulated markets, impurity control & compendial quality matter most. Regulated grades pay better. Generic grades move volume.

Major Chlorothiazide Producing Regions

India is the core production region for chlorothiazide today, with some capacity in China. India runs most of the world's chlorothiazide API capacity, backed by fine-chemical clusters and chloroaniline supply. Regional strength rests on cheap intermediates, scale, integration, and a broad generic base. China adds intermediate and API capacity with a low cost base and large chemical infrastructure. Europe and North America rely mainly on imported API, with finished-dose and specialty work at home. Across the map, the value chain spans meta-chloroaniline, the chlorosulfonation, the cyclization, and salt formation. A new plant would most likely start in an Indian fine-chemical cluster with chloroaniline supply and effluent capacity.

Key Chlorothiazide Producers

CTX Lifesciences

• Ranks among the leading global makers of chlorothiazide API, with a backward-integrated process.
• Produces chlorothiazide and related diuretics from its Surat, India facility.
• Competes on integration, quality & wide regulatory coverage.
• Regulatory record covers US FDA, EDQM, EMA & multi-country approvals.

Jigs Chemical

• Operates as an Indian API maker with chlorothiazide in its range.
• Produces chlorothiazide and other APIs for domestic and export markets.
• Competes on API breadth, capacity & a competitive cost base.
• Regulatory work covers Indian registration and export documentation.

Triveni Interchem

• Supplies chlorothiazide and other pharmaceutical intermediates and APIs from India.
• Produces and sources chlorothiazide for domestic and export markets.
• Competes on supply reliability, sourcing & a broad product range.
• Regulatory work covers Indian registration and export documentation.

Sun Pharmaceutical Industries

• Manufactures a broad API and finished-dose range, with diuretic capacity, from India.
• Runs synthesis and formulation of diuretics for regulated and emerging markets.
• Competes on scale, backward integration & wide regulatory coverage.
• Regulatory record covers US FDA, EU GMP & multi-country approvals.

Gansu Tianma Pharmaceutical

• Runs API and fine-chemical capacity from its base in China, with thiazide diuretics in its range.
• Produces chlorothiazide and related diuretics for domestic and export markets.
• Competes on scale, cost & a low cost base.
• Regulatory work covers Chinese and export standards for APIs.

Angle Bio Pharma

• Supplies chlorothiazide and other APIs from its base in India.
• Produces chlorothiazide for domestic and international markets.
• Competes on API breadth, capacity & a competitive cost base.
• Regulatory work covers Indian registration and export documentation.